Vaxil BioTherapeutics For Profit
Vaxil BioTherapeutics Ltd. (TASE:VAXL), is a clinical stage company developing a new class of synthetic therapeutic and preventive vaccines with promiscuous antigen specific T and B-cell activation, based on its proprietary VaxHit technology.
Founded Date:
2007-01-01
Headquarters:
Ness Ziona, HaMerkaz, Israel
Technology:
Meditations &mindfulness
Employee Number:
N/A
Industry:
Mental Health
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A